Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 3

2(40.0%)

Phase 2

2(40.0%)

N/A

1(20.0%)

5Total

Phase 3(2)

Phase 2(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06215859Phase 3Completed

Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy

Role: collaborator

NCT06215820Phase 3Completed

Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy

Role: collaborator

NCT05317312Phase 2Completed

Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.

Role: lead

NCT00915681Phase 2Terminated

Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom Poisoning

Role: lead

NCT02291016Not ApplicableCompleted

COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers

Role: collaborator

All 5 trials loaded